novo nordisk glp 1 oral US FDA accepts Nordisk's application for Wegovy for weight loss Novo Nordisk & Septerna Sign

Higher body weight can also reduce the response to some disease-modifying antirheumatic drugs (DMARDs) and biologic medications

Con ellas se puede llegar a perder un 17% del peso inicial

The inflammation that drives psoriatic symptoms also contributes to insulin resistance, making it harder for the body to manage blood sugar levels

It is imperative to prioritize informed decision-making and individualized care in this delicate period.

Until recently, therapeutic strategies remained limited to lifestyle interventions, with few pharmacological options demonstrating meaningful clinical benefit

Tirzepatide (Mounjaro): Also once weekly, despite its dual action on GLP-1 and GIP receptors